Comparing cognitive behavior therapy (CBT) and treatment with the antidepressant paroxetine with paroxetine alone in patients with social anxiety disorder

Effectiveness of cognitive behavioral therapy on social anxiety disorder and fear of negative evaluation: A comparative study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN96218088

Enrollment

Registered

2019-10-26

Start date

2018-05-04

Completion date

Unknown

Last updated

2021-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social anxiety disorder Mental and Behavioural Disorders

Interventions

All the consecutive social anxiety disorder (SAD) patients attending the study centre were assessed and informed about both treatment modalities in SAD. Treatment decisions of paroxetine (PX) alone or

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of social anxiety disorder based on ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research 2. Informed consent given 3. Aged 18 years or over

Exclusion criteria

Exclusion criteria: 1. Current level of severe depression with suicidal ideation 2. Substance dependence 3. Comorbid psychosis

Design outcomes

Primary

Measure	Time frame
1. Impact of social phobia assessed using the Liebowitz Social Anxiety Scale (LSAS) at baseline (0 week), and immediate post-treatment (16-18 weeks for CBT+PX and 16-20 weeks for PX only), and at follow-up 2 months after post treatment 2. Distress when meeting and talking with others assessed using the Social Interaction Anxiety Scale (SIAS) at baseline (0 week), and immediate post-treatment (16-18 weeks for CBT+PX and 16-20 weeks for PX only), and at follow-up 2 months after post treatment	—

Measure

Time frame

1. Impact of social phobia assessed using the Liebowitz Social Anxiety Scale (LSAS) at baseline (0 week), and immediate post-treatment (16-18 weeks for CBT+PX and 16-20 weeks for PX only), and at follow-up 2 months after post treatment 2. Distress when meeting and talking with others assessed using the Social Interaction Anxiety Scale (SIAS) at baseline (0 week), and immediate post-treatment (16-18 weeks for CBT+PX and 16-20 weeks for PX only), and at follow-up 2 months after post treatment

—

Secondary

Measure	Time frame
Social anxiety assessed using the Fear of Negative Evaluation-Brief Version (BFNE) at baseline (0 week), and immediate post-treatment (16-18 weeks for CBT+PX and 16-20 weeks for PX only), and at follow-up 2 months after post treatment	—

Countries

India

Contacts

Public ContactNarendra Samantaray

narendra.samantaray@gmail.com8763331977

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026